Ethics Isn’t a Pharma Value — It’s a Competitive Moat
Patient trust, physician credibility, and payer goodwill are not soft considerations alongside the balance sheet; they are the mechanism by which a pharmaceutical product generates revenue over time.
Forus Secures $150M Series C, Reaches $3B Valuation
Forus' $150 million Series C round was led by Bain Capital Ventures, with participation from Thrive Capital, General Catalyst, Accel, Redpoint, BoxGroup, Pear VC, Avra, Human Capital, Neo, Vast Ventures and SV Angel.
This Startup Wants to Make Glaucoma Surgery Recovery Easier
LEP Biomedical is developing a dissolvable implant that replaces weeks of self-administered eye drops after glaucoma surgery, aiming to fix the compliance problems that drive surgical failure rates as high as 40%.
Is Radiology at a Structural Breaking Point? What Will Move It to a Better Future?
The path forward requires much more than whack-a-mole point solution replacement. It requires a more critical look at redesigning the entire workflow architecture
presented by
Survey Reveals AI Adoption is Accelerating in Healthcare, But Readiness is Not
The 2026 Healthcare AI Readiness Index, a new report by Cotiviti and MedCity News, is based on a survey of 70 healthcare leaders over the summer and shares candid views of how they balance harnessing AI with operational, regulatory and security challenges it creates. Download the report today!